Literature DB >> 3761270

Infertility in mice infected genitally with a human strain of Chlamydia trachomatis.

M Tuffrey, P Falder, J Gale, R Quinn, D Taylor-Robinson.   

Abstract

Progesterone-treated C3H and TO mice were inoculated genitally with a human C. trachomatis strain, serovar E, designated N.I. 1 or with 2SP control medium. Of the C3H mice serving as controls 93% had litters by the end of a 6-month period compared to 31% of mice infected with chlamydiae. This infertility could not be explained by tubal occlusion, since the oviducts appeared normal at autopsy. Some of the mice were induced to superovulate. Eggs were never recovered from the oviducts on the inoculated sides of infertile mice although they were sometimes found in the lumen of the uninoculated oviducts. In contrast, eggs were recovered routinely from both oviducts of control mice. In addition, eggs and/or their accompanying cumulus cells could be seen in the periovarial space of mice inoculated with chlamydiae, indicating a failure of the transportation of eggs to the oviduct. This could explain the high incidence of ectopic pregnancies in women after chlamydial infection. No adverse effect on fertility was seen in TO mice inoculated genitally with strain N.I.1. Of the mice given 2SP medium, 73% had litters, but 87% of the mice inoculated with chlamydiae were also fertile. There was, however, a significantly greater variation in the birth weights of mice born to infected TO mothers than those born to control mice. This difference in the susceptibility of mouse strains suggests that a genetic predisposition should also be considered for man.

Entities:  

Mesh:

Year:  1986        PMID: 3761270     DOI: 10.1530/jrf.0.0780251

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  15 in total

1.  Susceptibility of mice to vaginal infection with Chlamydia trachomatis mouse pneumonitis is dependent on the age of the animal.

Authors:  S Pal; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Roxithromycin treatment of mouse chlamydial salpingitis and protective effect on fertility.

Authors:  J Zana; M Muffat-Joly; D Thomas; J Orfila; J Salat-Baroux; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Characterization of the Horizontal and Vertical Sexual Transmission of Chlamydia Genital Infections in a New Mouse Model.

Authors:  Sukumar Pal; Delia F Tifrea; Luis M de la Maza
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

4.  Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains.

Authors:  S A Morré; J M Lyons; J I Ito
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Evaluation of the activity of different quinolones in the experimental chlamydial salpingitis mouse model.

Authors:  D Thomas; J Orfila; E Bissac
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 6.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

7.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility.

Authors:  L M de la Maza; S Pal; A Khamesipour; E M Peterson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Differences in infectivity and induction of infertility: a comparative study of Chlamydia trachomatis strains in the murine model.

Authors:  Jennifer R Carmichael; Delia Tifrea; Sukumar Pal; Luis M de la Maza
Journal:  Microbes Infect       Date:  2012-12-31       Impact factor: 2.700

10.  Prevalence of Chlamydia trachomatis in cases of genital non-gonococcal infection according to microbiological and serological investigations.

Authors:  M Mazara; D Porta; G Gentili; A Giglio; G Palamara; C Spanò
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.